Document:

exv4w3

 

Exhibit 4.3

THIRD SUPPLEMENTAL INDENTURE

dated as of August 12, 2005

TO

INDENTURE

dated as of July 31, 2003

by and among

NEXTEL COMMUNICATIONS, INC.,

as Issuer,

and

BNY MIDWEST TRUST COMPANY,

as Trustee

 

 

THIRD SUPPLEMENTAL INDENTURE

     This THIRD SUPPLEMENTAL INDENTURE (the “Third Supplemental Indenture”) dated as of
August 12, 2005, by and among Nextel Communications, Inc., a Delaware corporation (the
“Company”), S-N Merger Corp., a Delaware corporation (“Successor”), and BNY Midwest
Trust Company, as trustee under the indenture referred to below (the “Trustee”).

W I T N E S S E T H :

     WHEREAS, the Company has heretofore executed and delivered to the Trustee an Indenture, dated
as of July 31, 2003 (the “Indenture”),as amended by the First Supplemental Indenture and
the Second Supplemental Indenture, each dated August 8, 2005, providing for the issuance of an
unlimited number of series of its Senior Serial Redeemable Notes (the “Securities”) of
which $4,779,846,500 aggregate principal amount have been issued and are outstanding on the date
hereof;

     WHEREAS, on the date hereof, the Company will be merged (the “Merger”) with and into
Successor, pursuant to the terms and conditions set forth in a Certificate of Merger filed with the
Secretary of State of the State of Delaware on the date hereof, resulting in Successor becoming the
successor to and obligor on the Securities and all of the Company’s obligations under the
Indenture;

     WHEREAS, Section 801 of the Indenture permits the Company to merge into another Person, if
such Person is the Surviving Entity, so long as certain conditions have been met;

     WHEREAS, Section 901(1) of the Indenture provides that, without the consent of the Holders of
any Securities, the Company, when authorized by a Board Resolution, and the Trustee, at any time
and from time to time, may enter into one or more supplemental indentures to evidence the
succession of another Person to the Company, and the assumption by any such successor of the
covenants of the Company under the Indenture and in the Securities;

     WHEREAS, the Company has furnished the Trustee pursuant to Sections 102, 801 and 903 (i) an
Officers’ Certificate and an Opinion of Counsel, each stating that the Merger and this Supplemental
Indenture comply with the requirements of Article Eight of the Indenture and that all conditions
precedent provided for in the Indenture relating to the Merger and to this Third Supplemental
Indenture have been complied with, and (ii) a copy of the Board Resolution authorizing the
execution of supplemental indentures, including this Third Supplemental Indenture, among other
things; and

     WHEREAS, all things necessary to authorize the assumption by Successor of the Company’s
obligations under the Indenture and to make this Third Supplemental Indenture when executed by the
parties hereto a valid and binding supplement to the Indenture have been done and performed.

     NOW THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the parties hereto mutually covenant
and agree for the equal and ratable benefit of the Holders of the Securities as follows:

 

 

     1. Definitions. Capitalized terms used herein without definition shall have the
meanings assigned to them in the Indenture. For all purposes of this Third Supplemental Indenture,
except as otherwise herein expressly provided or unless the context otherwise requires: (i) the
terms and expressions used herein shall have the same meanings as corresponding terms and
expressions used in the Indenture; and (ii) the words “herein,” “hereof” and “hereby” and other
words of similar import used in this Third Supplemental Indenture refer to this Third Supplemental
Indenture as a whole and not to any particular section hereof.

     2. Assumption of Obligations. As a result of the merger of the Company with and into
Successor, Successor will become the successor obligor under the Securities and, as of the
effective time of the Merger, Successor hereby expressly assumes the due and punctual payment of
the principal and any premium of and interest on all the Securities and the performance and
observance of every covenant and condition of the Indenture on the part of the Company to be
performed or observed, as required by Section 801 of the Indenture, and, therafer, all references
in the Indenture, as amended hereby, to “the Company” shall be deemed to be references to
Successor, as successor by merger to the Company under the Indenture.

     3. Separability Clause. In case any provision in this Third Supplemental Indenture
shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the
remaining provisions shall not in any way be affected or impaired thereby.

     4. Modification, Amendment and Waiver. The provisions of this Third Supplemental
Indenture may not be amended, supplemented, modified or waived, unless otherwise provided in the
Indenture, except by the execution of a supplemental indenture executed by the Company, and, to the
extent such amendment, supplement or waiver adversely affects the rights of any Holders, with the
Required Consent of such Holders. Any such amendment or supplemental indenture shall comply with
Article Nine of the Indenture. Until an amendment, waiver or other action by Holders becomes
effective, a consent thereto by a Holder of a Security hereunder is a continuing consent by the
Holder and every subsequent Holder of that Security or portion of the Security that evidences the
same obligation as the consenting Holder’s Security, even if notation of the consent, waiver or
action is not made on the Security. After an amendment, waiver or action becomes effective, it
shall bind every Holder.

     5. Ratification of Indenture; Third Supplemental Indenture Part of the Indenture.
Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all
the terms, conditions and provisions thereof shall remain in full force and effect. In the event
of a conflict between the terms and conditions of the Indenture and the terms and conditions of
this Third Supplemental Indenture, then the terms and conditions of this Third Supplemental
Indenture shall prevail. This Third Supplemental Indenture shall form a part of the Indenture for
all purposes, and every holder of Securities heretofore or hereafter authenticated and delivered
shall be bound hereby.

     6. Trust Indenture Act Controls. If any provision of this Third Supplemental
Indenture limits, qualifies or conflicts with any provision of the Trust Indenture Act of 1939, as
amended (“TIA”), that is required under the TIA to be part of and govern any provision of
this Third Supplemental Indenture, the provision of the TIA shall control. If any provision of
this Third Supplemental Indenture modifies or excludes any provisions of the TIA that may be so

2

 

modified or excluded, the provisions of the TIA shall be deemed to apply to the Indenture as
so modified or to be excluded by this Third Supplemental Indenture, as the case may be.

     7. Governing Law. THIS THIRD SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE AND
PERFORMED WITHIN THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICTS OF LAW.

     8. Trustee Makes No Representation. The statements herein are deemed to be those of
the Company. The Trustee makes no representation as to the validity or sufficiency of this Third
Supplemental Indenture.

     9. Multiple Originals. The parties may sign any number of copies of this Third
Supplemental Indenture. Each signed copy shall be an original, but all of them together represent
the same agreement. One signed copy is enough to prove this Third Supplemental Indenture.

     10. Effect of Headings. The Section headings herein are for convenience only and
shall not effect the construction thereof.

     11. Notices. Any request, demand, authorization, notice, waiver, consent or
communication to any of the parties shall be made as set forth in Sections 105 and 106 of the
Indenture.

     12. Successors. All agreements of the Company in respect of this Third Supplemental
Indenture shall bind its successor.

3

 

     IN WITNESS WHEREOF, this Third Supplemental Indenture has been duly executed by the Company,
Successor and the Trustee as of the date third written above.

	 	 	 	 	 
	 	 	NEXTEL COMMUNICATIONS, INC.
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Gary D. Begeman
	 

	 	 	 	 
	 

	 	Name:
	 	Gary D. Begeman
	 

	 	Title:
	 	Vice President
	 
	 	 	 	 
	 	 	S-N MERGER CORP.
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Charles R. Wunsch
	 

	 	 	 	 
	 

	 	Name:
	 	Charles R. Wunsch
	 

	 	Title:
	 	Vice President
	 
	 	 	 	 
	 	 	BNY MIDWEST TRUST COMPANY, as Trustee
	 
	 	 	 	 
	 

	 	By:
	 	/s/ D.G. Donovan
	 

	 	 	 	 
	 

	 	Name:
	 	D.G. Donovan
	 

	 	Title:
	 	Vice President

4exv4w1

 

EXHIBIT 4.1

Viseon, inc.

(formerly rsi systems, inc.)

SECURITIES PURCHASE AGREEMENT

 

SERIES B

CONVERTIBLE PREFERRED STOCK

AND

WARRANTS

 

Dated as of August ___, 2005

THE SECURITIES OFFERED FOR SALE PURSUANT TO THE TERMS OF THIS AGREEMENT AND
ALL SECURITIES THAT MAY BE ACQUIRED UPON CONVERSION OF THE SERIES B CONVERTIBLE
PREFERRED STOCK OR THE EXERCISE OF THE ACCOMPANYING WARRANTS HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAW OF
ANY STATE. SUCH SECURITIES MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE
STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION TO THE REGISTRATION
REQUIREMENTS OF SUCH ACT AND SUCH LAWS AND IN COMPLIANCE WITH THE CONDITIONS
SPECIFIED IN THIS AGREEMENT AND THE OTHER INVESTMENT DOCUMENTS IDENTIFIED HEREIN.

 

 

Securities Purchase Agreement

for

Series B Convertible Preferred Stock

and

Warrants

          This Securities Purchase Agreement (hereinafter the “Agreement”), dated as of
the ___th day of August 2005, is entered into by and between VISEON, Inc. f/k/a RSI Systems, Inc.,
a corporation duly authorized and existing pursuant to the laws of the state of Nevada, with its
principal offices located at 8445 Freeport Parkway, Suite 245, Irving, Texas 75063 (the
“Corporation”), and the purchaser whose name and address are set forth on the signature page hereof
(the “Purchaser” or the “Investor”).

          Whereas, The Company proposes to issue and sell to the Investor, subject to the terms and
conditions stated herein, the number of shares of the Company’s Series B Convertible Preferred
Stock and Series B Warrants set forth on the signature page hereof (collectively, the “Offered
Securities”), each to be issued in a private placement pursuant to an exemption from the
registration requirements of the Securities Act of 1933, as amended (the “Securities Act”),
pursuant to Section 4(2) of the Securities Act and Rule 506 of Regulation D thereunder, and with
respect to which ThinkEquity Partners LLC., (the “Placement Agent”) is acting as a placement agent.

          Now, Therefore, for and in consideration of the mutual agreements and covenants contained in
this Agreement, the Company and the Purchaser agree as follows:

	1.	 	Authorization of Sale of the Securities. Subject to the terms and conditions of this
Agreement, the Company has authorized the issuance and sale of up to Five Hundred
(500)shares of the Company’s Series B Convertible Preferred Stock (the “Convertible
Preferred”) convertible into the Company’s common stock, par value $0.01 per share (the
“Common Stock”), the terms and conditions of which are set forth in the Certificate of
Designation of Series B Convertible Preferred Stock in the form attached hereto as Exhibit A
and  Five Hundred (500) Series B Warrants to purchase up to 12,500,000 shares of
Common Stock (the “Warrant Shares”) each Series B Warrant entitling the Purchaser to acquire
Twenty-Five Thousand (25,000)shares of the Company’s Common Stock, at the purchase
price of one dollar and fifteen cents ($1.15) per share of Common Stock, subject to
adjustment, exercisable for five (5) years, subject to the terms, conditions and adjustments,
as set forth therein and evidenced by a warrant certificate in the form attached hereto as
Exhibit B (the “Warrants”). The Company reserves the right to increase or decrease the number
of shares of Convertible Preferred and Warrants sold in this private placement prior to the
Closing Date.
	 
	2.	 	Agreement to Sell and Purchase the Offered Securities. On the basis of the
representations, warranties and agreements herein contained, but subject to the terms and
conditions herein set forth, at the Closing (as defined in Section 3 herein below), the
Company agrees to sell to the Purchaser, and the Purchaser agrees to purchase from the
Company, the number of units set forth on the signature page of this Agreement, each unit
consisting of one share of the Company’s Series B Convertible Preferred Stock and one Series B
Warrant (each such unit, a “Unit”) for a purchase price Twenty-Five Thousand
Dollars ($25,000.00) per Unit.

 

 

	3.	 	Additional Purchasers. The Company proposes to enter into the same form of
purchase agreement with certain other investors (the “Other Purchasers”) and expects to
complete sales of the Offered Securities to them. The Purchaser and the Other Purchasers
are hereinafter sometimes collectively referred to as the “Purchasers” and this Agreement
and the agreements executed by the Other Purchasers are hereinafter sometimes collectively
referred to as the “Agreements”.
	 
	4.	 	Purchase, Sale and Delivery of Offered Securities at the Closing. The completion of
the purchase and sale of the Securities (the “Closing”) shall occur at the offices of Morrison
& Foerster LLP, 1290 Avenue of the Americas, New York, New York 10104 as soon as practicable
and as agreed to by the parties hereto, within three business days following the execution of
the Agreements, or on such later date or at such different location as the parties shall agree
in writing, but not prior to the date that the conditions for Closing set forth below have
been satisfied or waived by the appropriate party (the “Closing Date”).

	 	(a)	 	At the Closing, the Purchaser will buy from the Company, on the terms and
conditions set forth herein, and the Company will issue, sell and deliver to the
Purchaser, the Offered Securities by delivering shares of the Convertible Preferred,
the terms and conditions of which are set forth in the Designation of Series B
Convertible Preferred Stock in the form attached hereto as Exhibit A and Series B
Warrants to purchase shares of Common Stock, with each Series B Warrant entitling the
Purchaser to acquire Twenty-Five Thousand (25,000)shares of the Company’s
Common Stock, at the purchase price of one dollar and fifteen cents ($1.15)
per share, subject to adjustment, exercisable for five (5) years, subject to the terms,
conditions and adjustments, as set forth therein and evidenced by a warrant certificate
in the form attached hereto as Exhibit B each Warrant registered in the name of the
Purchaser, or, if so indicated on the Investor Questionnaire attached hereto as
Appendix I, in such nominee name(s) as designated by the Purchaser, and bearing an
appropriate legend referring to the fact that the Securities were sold in reliance upon
the exemption from registration under the Securities Act provided by Section 4(2)
thereof and Rule 506 thereunder. The Purchaser and any other permitted holders
(including, to the extent set forth herein, subsequent transferees) of the Offered
Securities will be entitled to the benefits of a registration rights agreement of even
date herewith among the Company and the Purchaser (the “Registration Rights
Agreement”), pursuant to which the Company agrees to file a registration statement with
the Securities and Exchange Commission (the “Commission”) registering the resale of the
common stock which may be obtained upon the conversion or exercise of, or received as
dividends on, the Offered Securities (the “Underlying Common Stock”) under the
Securities Act. The Company reserves the right to increase or decrease the number of
shares of Convertible Preferred and Warrants to be included in the Offered Securities.

	5.	 	Conditions Precedent. The Company’s obligation to complete the purchase and sale of
the Offered Securities and deliver such stock certificate(s) and Warrants to the Purchaser at
the Closing shall be subject to the following conditions, any one or more of which may

 

 

	 	 	be waived by the Company: (a) receipt by the Company of same-day funds in the full amount
of the purchase price for the Securities being purchased hereunder; (b) completion of the
purchases and sales under the Agreements with the Purchasers; and (c) the accuracy in all
material respects of the representations and warranties made by the Purchasers (as if such
representations and warranties were made on the Closing Date) and the fulfillment of those
undertakings of the Purchasers to be fulfilled prior to the Closing. The Purchaser has made
payment by wire transfer of funds in accordance with instructions from the Company in the
full amount of the purchase price of the Offered Securities, which Purchaser is purchasing
(the “Payment”). The Purchaser’s obligation to accept delivery of such stock certificate(s)
and Warrant Certificate(s) and to pay for the Offered Securities evidenced thereby shall be
subject to the following conditions, any one or more of which may be waived by the
Purchaser: (a) each of the representations and warranties of the Company made herein shall
be accurate in all material respects (except where the representations and warranties
already are qualified by materiality) as of the Closing Date; (b) the delivery to the
Purchaser by counsel to the Company of a legal opinion in a form reasonably satisfactory to
counsel to the Placement Agent; and (c) the fulfillment in all material respects of those
undertakings of the Company to be fulfilled prior to Closing. The Purchaser’s obligations
hereunder are expressly not conditioned on the purchase by any or all of the Other
Purchasers of the securities that they have agreed to purchase from the Company. The
Purchaser hereby agrees to be bound hereby upon (i) execution and delivery to the Company,
in care of the Placement Agent, of the signature page to this Agreement and (ii) if the
Company so chooses to accept this Agreement from the Purchaser, written acceptance on the
Closing Date by the Company and the Placement Agent of this Agreement, which shall be
confirmed by faxing to the Purchaser the signature page to this Agreement that has been
executed by the Company.
	 
	6.	 	Representations and Warranties of the Company. The Company represents and warrants
to, and agrees with, the Purchaser that:

	 	(a)	 	As of the date of this Agreement, all reports that have been required to be
filed by the Company under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”) have been filed under the Exchange Act and the rules and regulations of
the Commission thereunder. As of the date of this Agreement, all reports which have
been filed by the Company under the Securities Exchange Act, as amended (collectively,
the “Exchange Act Reports”) do not include any untrue statement of a material fact or
omit to state any material fact necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading. The Exchange Act
Reports, when they were filed with the Commission, conformed in all material respects
to the requirements of the Exchange Act and the rules and regulations of the Commission
thereunder.
	 
	 	(b)	 	The Company’s audited consolidated financial statements contained in the Form
10-KSB for the year ended June 30, 2004 (the “Form 10-KSB”) and the unaudited financial
statements contained in the Form 10-QSB for the quarter ended March 31, 2005 (the “Form
10-QSB”) including the notes contained therein present fairly, in accordance with U.S.
generally accepted accounting principles, the financial position of the Company as of
the dates indicated, and the results of its

 

 

	 	 	 	operations, cash flows and the changes in stockholders’ equity for the periods
therein specified, subject, in the case of unaudited financial statements for
interim periods, to normal year-end audit adjustments; and such financial statements
(including the related notes) have been prepared in accordance with U.S. generally
accepted accounting principles applied on a consistent basis throughout the periods
therein specified, except that unaudited financial statements may not contain all
footnotes required by generally accepted accounting principles. All liabilities,
contingent and other, of the Company and its subsidiaries, are set forth in the
financial statements as of June 30, 2004 and March 31, 2005 contained in the Form
10-KSB and Form 10-QSB respectively. Since March 31, 2005, (i) the Company and the
Subsidiaries have not incurred any liabilities or obligations, indirect, or
contingent, or entered into any oral or written agreement or other transaction that
is not in the ordinary course of business or that could reasonably be expected to
result in a material reduction in the future earnings of the Company and the
Subsidiaries; (ii) the Company and the Subsidiaries have not sustained any material
loss or interference with their businesses or properties from fire, flood,
windstorm, accident or other calamity not covered by insurance; (iii) other than
dividends payable on the Company’s Series A Convertible Preferred Stock, the Company
and the Subsidiaries have not paid or declared any dividends or other distributions
with respect to their capital stock and neither the Company nor any of the
Subsidiaries is in default in the payment of principal or interest on any
outstanding debt obligations; (iv) there has not been any change in the capital
stock of the Company or of any of the Subsidiaries other than as set forth in
Schedule 3(b), the sale of the Securities hereunder, shares or options issued
pursuant to employee equity incentive plans or purchase plans approved by the
Company’s Board of Directors and repurchases of shares or options pursuant to
repurchase plans already approved by the Company’s Board of Directors; (v) there has
not been any indebtedness not incurred in the ordinary course of business that is
material to the Company and the Subsidiaries, taken as a whole; (vi) there has not
been any other event that has caused a Material Adverse Effect and (vii) the number
of shares issuable and reserved for issuance pursuant to securities exercisable for,
or convertible into or exchangeable for any shares of capital stock as of the date
of this Agreement, is as described in Schedule 3(b) attached to this Agreement.
	 
	 	(c)	 	Virchow, Krause & Company, LLP, Certified Public Accountants, which has
expressed its opinion with respect to the financial statements and the notes thereto of
the Company as of June 20, 2003 and 2004 and for each of the two years in the period
ended June 30, 2004 included in the Form 10-KSB, is an independent accountant as
required by the Securities Act and the rules and regulations promulgated thereunder.
	 
	 	(d)	 	As of March 31, 2005, the Company had outstanding capital stock as set forth in
the Form 10-QSB; the issued and outstanding shares of the Company’s Common Stock have
been duly authorized and validly issued, are fully paid and nonassessable, have been
issued in compliance with all federal and state securities laws, were not issued in
violation of or subject to any preemptive rights or other

 

 

	 	 	 	rights to subscribe for or purchase securities, and conform in all material respects
to the description thereof contained in the Form 10-QSB and the Form 10-KSB (the
“Form 10-KSB” and together with the Form 10-QSB, the “SEC Periodic Filings”).
Except as set forth in Schedule 3(b) or disclosed in the SEC Periodic Filings, the
Company does not have outstanding any options to purchase, or any preemptive rights
or other rights to subscribe for or to purchase, any securities or obligations
convertible into, or any contracts or commitments to issue or sell, shares of its
capital stock or any such options, rights, convertible securities or obligations.
The description of the Company’s stock, stock bonus and other stock plans or
arrangements and the options or other rights granted and exercised thereunder, set
forth in the SEC Periodic Filings accurately and fairly presents all material
information with respect to such plans, arrangements, options and rights. With
respect to each Subsidiary, to the extent relevant under applicable law, (i) all the
issued and outstanding shares of each Subsidiary’s capital stock have been duly
authorized and validly issued, are fully paid and nonassessable, have been issued in
compliance with applicable federal and state securities laws, and were not issued in
violation of or subject to any preemptive rights or other rights to subscribe for or
purchase securities, and (ii) there are no outstanding options to purchase, or any
preemptive rights or other rights to subscribe for or to purchase, any securities or
obligations convertible into, or any contracts or commitments to issue or sell,
shares of the Subsidiary’s capital stock or any such options, rights, convertible
securities or obligations.
	 
	 	(e)	 	The Offered Securities have been duly authorized by the Company and, when
delivered and paid for pursuant to this Agreement, will have been duly executed,
authenticated, issued and delivered, will be validly issued, fully paid and
non-assessable (in the case of Series B Convertible Preferred Stock) and will
constitute valid and legally binding obligations of the Company, enforceable in
accordance with their terms.
	 
	 	(f)	 	The Company has been duly incorporated, is validly existing and in good
standing under the laws of the State of Nevada, with power and authority (corporate and
other) to own its properties and conduct its business as described in the Exchange Act
Reports. The Company is qualified to do business as a foreign corporation in each
jurisdiction in which qualification is required, except where failure to qualify would
not reasonably be expected to have a Material Adverse Effect (as defined herein).
	 
	 	(g)	 	Except as disclosed in the SEC Periodic Filings, the Company and the
Subsidiaries have no material contracts. Any contracts described in the SEC Filings
that are material to the Company and the Subsidiaries, taken as a whole, are in full
force and effect on the date hereof; and neither the Company nor any the Subsidiaries
is, nor to the Company’s knowledge, any other party, is in breach of or default under
any of such contracts that would have a Material Adverse Effect.

 

 

	 	(h)	 	Except as disclosed in the SEC Filings, (1) there are no legal or governmental
actions, suits or proceedings pending and (2) to the Company’s knowledge, there are no
inquiries, investigations, or legal or governmental actions, suits, or proceedings
threatened to which the Company or any of the Subsidiaries is or may be a party or of
which property owned or leased by the Company or any of the Subsidiaries is or may be
the subject, or related to environmental or discrimination matters, which actions,
suits or proceedings, individually or in the aggregate, might reasonably be expected to
have a Material Adverse Effect. No labor disturbance by the employees of the Company
exists or, to the Company’s knowledge, is imminent that might reasonably be expected to
have a Material Adverse Effect. Neither the Company nor any of the Subsidiaries is
party to or subject to the provisions of any injunction, judgment, decree or order of
any court, regulatory body, administrative agency or other governmental body, which
might reasonably be expected to have a Material Adverse Effect.
	 
	 	(i)	 	Each wholly-owned subsidiary of the Company (each, a “Subsidiary”) has been
duly incorporated, is validly existing in good standing under the laws of the
jurisdiction of its incorporation, with power and authority (corporate and other) to
own its properties and conduct its business as described in the Exchange Act Reports;
each Subsidiary is duly qualified to do business as a foreign corporation in good
standing in all other jurisdictions in which its ownership or lease of property or the
conduct of its business requires such qualification; all of the issued and outstanding
capital stock of each Subsidiary has been duly authorized and validly issued and is
fully paid and nonassessable and is owned free from liens, encumbrances and defects.
The Subsidiaries listed in Exhibit 21.1 to the Form 10-KSB constitute the only
subsidiaries of the Company.
	 
	 	(j)	 	When the Offered Securities are delivered and paid for pursuant to this
Agreement, such Offered Securities will be convertible into or exercisable for the
Company’s Common Stock in accordance with the terms of such Offered Securities. The
aggregate number of shares of the Company’s Common Stock initially issuable upon
conversion or exercise of, and as payment of dividends on, such Offered Securities has
been duly authorized and reserved for issuance upon such conversion, exercise, or
payment and, when issued upon such conversion, exercise or payment, will be validly
issued, fully paid and nonassessable. The outstanding Common Stock of the Company has
been duly authorized and validly issued, is fully paid and nonassessable and conforms
to the description thereof contained in the Exchange Act Reports; and the shareholders
of the Company have no preemptive rights with respect to the Offered Securities or the
Underlying Common Stock. Except as set forth in the Exchange Act Reports or on
Schedule 3(b), there are no outstanding rights, options, warrants, right of first
refusal agreements, commitments or similar rights for the purchase or acquisition from
the Company or any of its Subsidiaries of any securities of the Company or any of its
Subsidiaries. The Offered Securities and the Underlying Common Stock, when issued,
will be free and clear of all pledges, liens, encumbrances and other restrictions
(other than those arising under federal or state securities laws as a result of the
private placement of the Offered Securities). No co-sale right, right

 

 

	 	 	 	of first refusal or other similar right exists with respect to the Offered
Securities and the Underlying Common Stock or the issuance and sale thereof.
Excepting certain holders of the Company’s Series A Preferred Stock and Warrants,
the issuance and sale of the Offered Securities and the Underlying Common Stock will
not result in a right of any holder of Company securities to adjust the exercise,
conversion, exchange or reset price under such securities. No further approval or
authorization of any stockholder, the Board of Directors of the Company or others is
required for the issuance and sale of the Offered Securities and Underlying Common
Stock. The issuance and sale of the Offered Securities and Underlying Common Stock
under the Agreements does not contravene the rules and regulations of any
self-regulatory organization, exchange or market (an “SRO”). Except for the
registration rights listed on Schedule 2, no holder of any of the securities of the
Company has any rights (“demand,” “piggyback” or otherwise) to have such securities
registered by reason of the intention to file, filing or effectiveness of a
registration statement.
	 
	 	(k)	 	Except for the Engagement Letter Agreement between the Company and Placement
Agent dated June 24, 2005 (the “Placement Agency Agreement”), there are no contracts,
agreements or understandings between the Company and any person in connection with the
sale of the Offered Securities that would give rise to a valid claim against the
Company or the Purchaser for a brokerage commission, finder’s fee or other like
payment.
	 
	 	(l)	 	No consent, approval, authorization, or order of, or filing with, any
governmental agency or body, any SRO, or any court is required for the consummation of
the transactions contemplated by this Agreement and the Registration Rights Agreement
in connection with the issuance and sale of the Offered Securities and the Underlying
Common Stock by the Company except for post-Closing compliance with Blue Sky laws of
the jurisdictions, if any, where any Purchaser may reside and the order of the
Commission declaring the Registration Statement (as defined in the Registration Rights
Agreement) effective.
	 
	 	(m)	 	The Company has full legal right, corporate power and authority to enter into
this Agreement the Registration Rights Agreement and to perform the transactions
contemplated hereby. The execution, delivery and performance of this Agreement by the
Company and the consummation of the transactions herein contemplated will not violate
any provision of the certificate of incorporation or bylaws of the Company or any of
the Subsidiaries and will not result in the creation of any lien, charge, security
interest or encumbrance upon any assets of the Company or any of the Subsidiaries
pursuant to the terms or provisions of, and will not (i) conflict with, result in the
breach or violation of, or constitute, either by itself or upon notice or the passage
of time or both, a default under (A) any agreement, lease, franchise, license, permit
or other instrument to which the Company or any of the Subsidiaries is a party or by
which the Company or any of the Subsidiaries or any of their respective properties may
be bound or affected and in each case which would have a Material Adverse Effect, or
(B) to the Company’s knowledge, any statute or any judgment, decree, order, rule or

 

 

	 	 	 	regulation of any court or any regulatory body, administrative agency or other
governmental body applicable to the Company or any of the Subsidiaries or any of
their respective properties where such conflict, breach, violation or default is
likely to result in a Material Adverse Effect. No consent, approval, authorization
or other order of any court, regulatory body, administrative agency or other
governmental body is required for the execution and delivery of this Agreement or
the consummation of the transactions contemplated by this Agreement, except for
compliance with the blue sky laws and federal securities laws applicable to the
offering of the Securities. Upon the execution and delivery of this Agreement and
the Warrants, and assuming the valid execution and delivery thereof together with
the Payment by the Purchaser, each of this Agreement and the Warrants will
constitute a valid and binding obligation of the Company, enforceable in accordance
with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors and
contracting parties’ rights generally and except as enforceability may be subject to
general principles of equity (regardless of whether such enforceability is
considered in a proceeding in equity or at law) and except as the indemnification
agreements of the Company in Section 8(b) hereof may be limited by federal or state
securities laws or the public policy underlying such laws.
	 
	 	(n)	 	The Company and the Subsidiaries have good and marketable title to all real
properties and all other properties and assets reflected as owned by them in the
Current Exchange Act Filings (as defined herein), in each case free from liens and
encumbrances other than as set forth in the Company’s Form 10-KSB for the twelve month
period ending June 30, 2004 or in the Company’s Form 10-QSB for the three month period
ending March 31, 2005 filed with Commission (the “Current Exchange Act Reports”). All
real properties and all other properties and assets owned by the Company and the
Subsidiaries, that are material to the business of either of them or that have a value
of $25,000 or more, are free of any defects that would materially affect the value
thereof or materially interfere with the use made or to be made thereof by them. The
Company and its Subsidiaries hold any leased real or personal property under valid and
enforceable leases with no exceptions (i) that would materially interfere with the use
made or to be made thereof by them or (ii) are not materially significant in relation
to its business taken as a whole. The Company and the Subsidiaries own or lease all
such properties as are necessary to their respective operations as now conducted.
	 
	 	(o)	 	Neither the Company nor any of the Subsidiaries has been advised, nor has
reason to believe, that it is not conducting its business in compliance with all
applicable laws, rules and regulations of the jurisdictions in which it is conducting
its business, including, without limitation, all applicable local, state and federal
environmental laws and regulations, except where failure to be so in compliance would
not have a would have a material adverse effect on the business, assets, operations,
financial condition results of operations or prospects of the Company (a “Material
Adverse Effect”). Each of the Company and the Subsidiaries has all franchises,
licenses, certificates and other authorizations from such federal, state,

 

 

	 	 	 	local or other foreign or domestic government or governmental agency, department or
body that are currently required for the operation of the business of the Company
and the Subsidiaries as currently conducted, except where the failure to posses
currently such franchises, licenses, certificates and other authorizations is not
reasonably expected to have a Material Adverse Effect. The Company and the
Subsidiaries have not received any notice of proceedings relating to the revocation
or modification of any such permit that, if the subject of an unfavorable decision,
ruling or finding, could reasonably be expected to have a Material Adverse Effect.
	 
	 	(p)	 	The Company and the Subsidiaries have, own, or possess or can acquire adequate
trademarks, trade names and other rights to inventions, know-how, patents, copyrights,
confidential information and other intellectual property (collectively, “intellectual
property rights”) necessary to conduct the business now operated by them, or presently
employed by them, and have not received any notice of infringement of, or conflict with
the intellectual property rights owned by others with respect to such intellectual
property rights.
	 
	 	(q)	 	There are no pending actions, suits or proceedings against or affecting the
Company or any Subsidiary or any of their respective properties or officers or
directors, in their capacity as such, that, if determined adversely to the Company,
would have a Material Adverse Effect, or would materially and adversely affect the
ability of the Company to perform its obligations under this Agreement the Registration
Rights Agreement or the Offered Securities or which are otherwise material in the
context of the sale of the Offered Securities; and to the best of the Company’s
knowledge and belief, no such actions, suits or proceedings are threatened.
	 
	 	(r)	 	Each of the Company and the Subsidiaries has filed all necessary federal, state
and foreign income and franchise tax returns and has paid or accrued all taxes shown as
due thereon, and neither the Company nor any of the Subsidiaries has knowledge of a tax
deficiency that has been or might be asserted or threatened against it that might
reasonably be expected to have a Material Adverse Effect.
	 
	 	(s)	 	On the Closing Date, all stock transfer or other taxes (other than income
taxes) which are required to be paid in connection with the sale and transfer of the
Securities to be sold to the Purchaser hereunder will be, or will have been, fully paid
or provided for by the Company and all laws imposing such taxes will be or will have
been complied with.
	 
	 	(t)	 	The Company is in compliance with the applicable requirements of the
Sarbanes-Oxley Act of 2002, and the rules and regulations thereunder, that are
currently in effect and is actively taking steps to ensure that it will be in
compliance with other applicable provisions of such Act not currently in effect at all
times after the effectiveness of such provisions except where such noncompliance would
not have or reasonably be expected to result in a Material Adverse Effect or which
would be reasonably likely to have a material adverse effect on the transactions

 

 

	 	 	 	contemplated hereby or by the Registration Rights Agreement. The Company and each
Subsidiary maintains a system of internal accounting controls sufficient to provide
the Company’s management with timely and accurate information as to its financial
position.
	 
	 	(u)	 	The Company has established disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the Company and designed such disclosure
controls and procedures to ensure that material information relating to the Company,
including its Subsidiaries, is made known to the certifying officers by others within
those entities, particularly during the period in which the Company’s Form 10-KSB or
10-QSB, as the case may be, is being prepared. The Company’s certifying officers have
evaluated the effectiveness of the Company’s controls and procedures as of the date
required by the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations
thereunder (such date, the “Evaluation Date”). The Company has presented in the
applicable Form 10-KSB or Form 10-QSB the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no significant
changes in the Company’s internal controls (as such term is defined in Regulation S-B)
or, to the Company’s knowledge, in other factors that could significantly affect the
Company’s internal controls. The Company meets the requirements for the use of Form
SB-2 for the registration of the resale of the Offered Securities and the Underlying
Common Stock by the Purchaser.
	 
	 	(v)	 	The Company is not and is not required to be registered under Section 8 of the
United States Investment Company Act of 1940, as amended (the “Investment Company Act”)
and at all times maintains satisfactory controls and procedures to provide accurate
data upon which to base such statement; the Company’s intended use of the proceeds of
the Offering are to retire long and short term indebtedness, and for general working
capital for the continued operation of its business and the Company is not and, after
giving effect to the offering and sale of the Offered Securities and the application of
the proceeds thereof as described in the Offering Document, will not be an “investment
company” or an “affiliated person” of, or “promoter” or “ principal underwriter” for an
investment company as such term is defined in the Investment Company Act.
	 
	 	(w)	 	All offers and sales of securities by the Company have been made by the Company
in compliance with the Securities Act and the rules and regulations of the Commission
thereunder.
	 
	 	(x)	 	Assuming the accuracy of the representations of the Purchaser in the Investor
Questionnaires and herein, the offer and sale of the Offered Securities by the Company
to the Purchaser, and the issuance of the Underlying Common Stock, in the manner
contemplated by this Agreement will be exempt from the registration requirements of the
Securities Act by reason of Section 4(2) thereof and Regulation D thereunder and will
be exempt from and from the registration or

 

 

	 	 	 	qualification requirements of the laws of any applicable state or United States
jurisdiction.
	 
	 	(y)	 	The Company has not distributed and will not distribute prior to the Closing
Date any offering material in connection with the offering and sale of the Offered
Securities other than the SEC Filings. Neither the Company nor any person acting on
its behalf has in the past or will hereafter take any action independent of the
Placement Agents to sell, offer for sale or solicit offers to buy any securities of the
Company that would subject the offer, issuance or sale of the Securities, as
contemplated by this Agreement, to the registration requirements of Section 5 of the
Securities Act. Neither the Company, nor any of its affiliates, nor any person acting
on its or their behalf, has directly or indirectly made any offers or sales in any
security or solicited any offers to buy any security under circumstances that would
require registration under the Securities Act of the issuance of the Offered Securities
to Purchaser. The issuance of the Offered Securities to the Purchaser will not be
integrated with any other issuance of the Company’s securities (past, current or
future) for purposes of the Securities Act or any applicable rules of the Nasdaq Stock
Market. The Company will not make any offers or sales of any security that would cause
the offering of the Offered Securities to be integrated with any other offering of
securities by the Company for purposes of any registration requirement under the
Securities Act or any applicable rules of the Nasdaq Stock Market.
	 
	 	(z)	 	The Company is in material compliance with all applicable securities (or “Blue
Sky”) laws of the states of the United States, which including, without limitation, the
state in which the Purchaser resides and of each other state in which the Offering has
been made to the Purchaser, as identified in writing by the Placement Agent to the
Company.
	 
	 	(aa)	 	The Company and the Subsidiaries maintain insurance of the types and in the
amounts that the Company reasonably believes is adequate for their businesses,
including, but not limited to, insurance covering all real and personal property leased
by the Company and the Subsidiaries against theft, damage, destruction, acts of
vandalism and all other risks customarily insured against by similarly situated
companies, all of which insurance is in full force and effect.
	 
	 	(bb)	 	The Company has not entered and will not enter into any contractual arrangement
with respect to the distribution of the Offered Securities or the Underlying Common
Stock except for this Agreement, the Registration Rights Agreement and the Placement
Agency Agreement.
	 
	 	(cc)	 	The Company is subject to the reporting requirements of the Exchange Act and
has filed all reports required thereby. There exist no facts or circumstances
(including without limitation any required approvals or waivers or any circumstances
that may delay or prevent the obtaining of accountant’s consents) that reasonably could
be expected to prohibit or delay the preparation and filing of

 

 

	 	 	 	the Registration Statement on Form SB-2 that will be available for the resale of the
Underlying Common Stock by the Purchaser.
	 
	 	(dd)	 	The Company has not taken, and will not take, directly or indirectly, any
action designed to cause or result in, or which has constituted or which might
reasonably be expected to constitute, the stabilization or manipulation of the price of
the shares of the Common Stock to facilitate the sale or resale of the Securities.
	 
	 	(ee)	 	The Company has made available all material public information, as well as the
Howison and Arnott Opinion (as defined herein), in connection with the business of the
Company and the transactions contemplated by this Agreement, and no representation or
warranty made, nor any document, statement, or financial statement prepared or
furnished by the Company in connection herewith contains any untrue statement of
material fact, or omits to state a material fact necessary to make the statements or
facts contained herein or therein, in light of the circumstances under which they were
made, not misleading. The Company confirms that neither it nor any person acting on
its behalf has provided the Purchaser or its agents or counsel with any information,
taking into account the disclosure and statements included in the Howison and Arnott
Opinion, that the Company believes constitutes material, non-public information. The
Company understands and confirms that the Purchaser will rely on the foregoing
representation in effecting transactions in securities of the Company.
	 
	 	(ff)	 	The Company shall not use the Purchaser’s name or the name of any of its
affiliates in any advertisement, announcement, press release or other similar public
communication unless it has received the prior written consent of the Purchaser for the
specific use contemplated or as otherwise required by applicable law or regulation.
	 
	 	(gg)	 	No transaction has occurred between or among the Company, any of the
Subsidiaries and their affiliates, officers or directors or any affiliate or affiliates
of any such officer or director that is required to have been described under
applicable securities laws in its Exchange Act filings and is not so described in such
filings.
	 
	 	(hh)	 	There is no transaction, arrangement or other relationship between the Company
and an unconsolidated or other off-balance sheet entity that is required to be
disclosed by the Company in its Exchange Act filings and is not so disclosed or that
otherwise would be reasonably likely to have a Material Adverse Effect. There are no
such transactions, arrangements or other relationships with the Company that may create
contingencies or liabilities that are not otherwise disclosed by the Company in its
Exchange Act filings.
	 
	 	(ii)	 	For the purposes of this Agreement, the term “Intellectual Property” means all
intellectual property rights of the Company and its Subsidiaries, including (a) all
inventions, including discoveries related thereto, conceived of and reduced to practice
as of the date hereof, whether patentable or not in any jurisdiction,

 

 

	 	 	 	patents, applications for patents (including, without limitation, divisions,
continuations, continuations in part and renewal applications), and any renewals,
extensions or reissues thereof, in any jurisdiction; (b) trademarks, service marks,
brand names, certification marks, trade dress, assumed names, trade names and other
indications of origin, the goodwill associated with the foregoing and registrations
in any jurisdiction of, and applications in any jurisdiction to register, the
foregoing, including any extension, modification of or renewal of any such
registration or application; (c) computer software (including software, data, and
related documentation); (d) non-public information, trade secrets, know-how
(including, without limitation, research and development, formulas, compositions,
manufacturing and production processes and techniques, technical data, designs,
drawings and specifications) and confidential information and rights in any
jurisdiction to limit the use or disclosure thereof by any person or entity; (e)
writings or other works, whether copyrightable or not in any jurisdiction,
registrations or applications for registration of copyrights in any jurisdiction,
and any renewals or extensions thereof; (f) any similar intellectual property
rights, and (g) any claims or causes of action arising our of or related to any
infringement or misappropriation of any of the foregoing.

	 	(i)	 	The Company and its Subsidiaries own all right, title and
interest in and to all of the Intellectual Property owned by the, free and
clear of any and all liens, encumbrances or other adverse claims or interests
of any kind or nature, except as previously disclosed in any Current Exchange
Act Report.
	 
	 	(ii)	 	All of the Intellectual Property necessary to the operation of
the business of the Company and its Subsidiaries is, to the knowledge of the
Company, valid and enforceable, without any qualification, limitation or
restriction thereon or on the use thereof and the Company has not received any
notice or claim (whether written, oral or otherwise) challenging or questioning
the validity or enforceability of any of the Intellectual Property or
indicating an intention on the part of any third party to bring a claim that
any of the Intellectual Property is invalid or unenforceable or has been
misused which has not been previously disclosed in any Current Exchange Act
Report or as discussed in the attached due diligence opinion of Howison and
Arnott (the “Howison and Arnott Opinion”), nor is there a reasonable basis for
a claim that any of the Intellectual Property is invalid or unenforceable or
has been misused, and, with respect to all patents included in the Intellectual
Property, to the knowledge of the Company, there is no relevant prior art
pertaining to any issued patents thereof that was not disclosed during the
prosecution of the patent application(s) therefor and which if such prior art
had been disclosed may have affected the prosecution thereof or the scope of
the patent claims ultimately granted in respect thereof.
	 
	 	(iii)	 	The Company and its Subsidiaries have not taken any action or
failed to take any action (including the manner in which they have conducted
its

 

 

	 	 	 	business, or used or enforced, or failed to use or enforce, any of the
Intellectual Property) that would result in the abandonment, cancellation,
forfeiture, relinquishment, invalidation or unenforceability of any of the
Intellectual Property (including, with respect to the patents included in
the Intellectual Property, failing to disclose any known material prior art
in connection with the prosecution of patent applications, and with respect
to the copyrights included in the Intellectual Property, failing to disclose
required information to the United States Copyright Office or any other
copyright registry). The Company and each Subsidiary has taken reasonable
steps to protect and maintain its rights in and to the Intellectual
Property. All registered trademarks, service marks, and copyrights included
in the Intellectual Property have been registered or filed, and all patents
included in the Intellectual Property have been filed and obtained, in
accordance with all applicable legal requirements and are currently in
effect and in compliance with all applicable legal requirements (including,
in the case of registered trademarks or service marks, the timely
post-registration filing of affidavits of use and incontestability and
renewal applications), and without limiting the generality of any of the
foregoing, the Company and its Subsidiaries have timely paid all filing,
examination, issuance, post registration and maintenance fees, annuities and
the like associated with or required with respect to any of the Intellectual
Property.
	 
	 	(iv)	 	No patent, trademark or service mark included in the
Intellectual Property has been or is now involved in any interference, reissue,
reexamination, opposition or cancellation proceeding, that is material to the
ownership, existence or validity of such Intellectual Property, which has not
been previously disclosed in any Current Exchange Act Report or as discussed in
the attached due diligence opinion of Howison and Arnott and, to the Company’s
knowledge and belief, (A) no such action is or has been threatened with respect
to any such patent, trademark or service mark, and (B) there is no patent or
patent application of any third party potentially interfering with any such
patent.
	 
	 	(v)	 	To the knowledge of the Company, there has been no prior use of
any of the trademarks and service marks included in the Intellectual Property
by any third party, which would confer upon such party superior rights in such
marks. All registered trademarks or service marks included in the Intellectual
Property are being used, have been continuously used in the form appearing in,
and in connection with, the goods and services listed in their respective
registration certificates and applications therefor, respectively.
	 
	 	(vi)	 	The Company and the Subsidiaries have not disclosed, nor are
they under any contractual or other obligation to disclose, to another third
party any trade secrets included in the Intellectual Property, except pursuant
to a confidentiality and non-disclosure agreement, and, to the Company’s
knowledge, no third party has materially breached any such agreement.

 

 

	 	(vii)	 	The Company has the right to practice all inventions disclosed
in the patents included in the Intellectual Property.
	 
	 	(viii)	 	The Intellectual Property constitutes all of the intellectual property rights
necessary for the conduct of the current business activities of the Company and
its Subsidiaries.

	 	(jj)	 	The Company and its Subsidiaries are not a party to any action or proceeding
that involves or involved a claim of infringement, misappropriation or other wrongful
use or exploitation, either (i) by the Company or any Subsidiary against any third
party or (ii) by any third party against the Company or any Subsidiary, pertaining to
the Company’s use of any of the Intellectual Property, nor has any such claim been made
(whether written oral or otherwise) or threatened or is there any reasonable basis
therefor, which has not been previously disclosed in any Current Exchange Act Report.
None of the Intellectual Property is subject to any outstanding order, judgment,
decree, stipulation or agreement restricting the use, exercise, practice or other
exploitation thereof by the Company or any Subsidiary, with the exception of certain
Intellectual Property licensed to third parties. To the knowledge of the Company,
neither the Intellectual Property nor the products sold by the Company or any
Subsidiary enveloped, practiced, copied, modified (including the creation of
derivatives), displayed, made, sold, offered for sale, marketed, used, leased, licensed
or sublicensed, imported, exported or otherwise distributed, disposed of, otherwise
exercised or exploited by or for the Company, nor the activities or operations of
Company or any Subsidiary infringe, misappropriate or otherwise inappropriately
conflict with or violate, or has any of them infringed, misappropriated, or otherwise
inappropriately conflicted with or violated, any intellectual property right or other
right of any third party.
	 
	 	(kk)	 	Each current employee, independent contractor and consultant to the Company who
has participated in the development of any of the Intellectual Property has (a)
executed an agreement requiring each of them to maintain in strict confidence the trade
secrets and information of the Company related to the Intellectual Property and (b)
properly assigned such individual’s rights in such Intellectual Property to the Company
or such work product otherwise constitutes the property of the Company as a work made
for hire. The Company and its Subsidiaries are not utilizing (A) any inventions of any
independent contractors or consultants, or confidential information (including trade
secrets) of any third party to which any independent contractors or consultants have
been exposed, and (B) any inventions of any employees of the Company made, or any
confidential information (including trade secrets) of another person to which any
employees were exposed, prior to their employment by the Company, in each case
excluding any inventions or confidential information that have been duly assigned in
writing to the Company. To the Company’s knowledge and belief, at no time during the
conception of or reduction to practice of any of the Intellectual Property was any
developer, inventor or other contributor to such Intellectual Property operating under
any grants from any governmental entity or private source, or performing research
sponsored by any governmental entity or private source.

 

 

	 	(ll)	 	Except as set forth in the Company’s Exchange Act Reports, none of the officers
or directors of the Company and, to the knowledge of the Company, none of the employees
of the Company is presently a party to any transaction with the Company or any
Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services
to or by, providing for rental of real or personal property to or from, or otherwise
requiring payments to or from any officer, director or such employee or, to the
knowledge of the Company, any entity in which any officer, director, or any such
employee has a substantial interest or is an officer, director, trustee or partner.
	 
	 	(mm)	 	Based on the financial condition of the Company as of the Closing Date (and
assuming that the Closing shall have occurred), (i) the Company’s fair saleable value
of its assets exceeds the amount that will be required to be paid on or in respect of
the Company’s existing debts and other liabilities (including known contingent
liabilities) as they mature; (ii) the Company’s assets do not constitute unreasonably
small capital to carry on its business for the current fiscal year as now conducted and
as proposed to be conducted including its capital needs taking into account the
particular capital requirements of the business conducted by the Company, and projected
capital requirements and capital availability thereof; and (iii) the current cash of
the Company, together with the proceeds that the Company would receive, were it to
liquidate all of its assets, after taking into account all anticipated uses of the
cash, would be sufficient to pay all amounts on or in respect of its debt when such
amounts are required to be paid. The Company does not intend to incur debts beyond its
ability to pay such debts as they mature (taking into account the timing and amounts of
cash to be payable on or in respect of its debt).
	 
	 	(nn)	 	No other purchaser of Series B Preferred Stock and Series B Warrants has
received, or will receive, more favorable terms, conditions or covenants than those
contained herein and no consideration shall be offered or paid for the amendment,
consent to a waiver or modification of any provision of this Agreement, the Warrant or
the Registration Rights Agreements unless the same consideration is also offered to all
parties to such agreements. Notwithstanding the forgoing or any other provision
hereof, each Purchaser acknowledges and agrees that the percentages set forth in
Paragraph 19 of any Series B Warrant and the application thereof with respect to a
holder may be different as to any other holder and that any deviation as such shall not
constitute a breach of this Agreement or any other agreement related to or in
furtherance of the transaction contemplated hereby.
	 
	 	(oo)	 	The Company acknowledges that the issuance of the Offered Securities may result
in dilution of the outstanding shares of Common Stock, which dilution may be
substantial under certain market conditions. The Company further acknowledges that its
obligations under this Agreement, the Convertible Preferred and the Warrant, including
without limitation its obligation to issue the Common Stock, Conversion Shares and
Warrant Shares thereunder, are unconditional and

 

 

	 	 	 	absolute and not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have
against any Investor and regardless of the dilutive effect that such issuance may
have on the ownership of the other stockholders of the Company.
	 
	 	(pp)	 	The Company acknowledges and agrees that, except for the information provided
in Part III, Section 2 of the Investor Questionnaire, (i) to the knowledge of the
Company, none of the Investors have been asked to agree, nor has any Investor agreed,
to desist from purchasing or selling, long and/or short, securities of the Company, or
“derivative” securities based on securities issued by the Company or to hold the
Securities for any specified term; (ii) that past or future open market or other
transactions by any Investor, including short sales, and specifically including,
without limitation, short sales or “derivative” transactions, before or after the
closing of this or future private placement transactions, may negatively impact the
market price of the Company’s publicly-traded securities; (iii) that any Investor, and
counter parties in “derivative” transactions to which any such Investor is a party,
directly or indirectly, presently may have a “short” position in the Common Stock; and
(iv) that, to the knowledge of the Company, each Investor shall not be deemed to have
any affiliation with or control over any arm’s length counter party in any “derivative”
transaction. The Company further understands and acknowledges that (a) one or more
Investors may engage in hedging activities at various times during the period that the
Shares, Warrants and/or Warrant Shares are outstanding and (b) such hedging activities
(if any) could reduce the value of the existing stockholders’ equity interests in the
Company at and after the time that the hedging activities are being conducted. The
Company acknowledges that such aforementioned hedging activities do not constitute a
breach of this Agreement, the Convertible Preferred, the Warrants or any of the
documents executed in connection herewith.

	7.	 	Representations by the Purchaser: Resale by the Purchaser. The Purchaser represents,
warrants and acknowledges and agrees with the Company and Placement Agent as follows:

	 	(a)	 	The Purchaser is an “Accredited Investor” (as such term is defined in Rule 501
of Regulation D promulgated under the Securities Act). By reason of his business and
financial experience, the Purchaser has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and
risks of the investment in the Offered Securities and the Underlying Common Stock, has
the capacity to protect the Purchaser’s own interests and is able to bear the economic
risk of such investment. The Purchaser has had an opportunity to review all publicly
disclosed financial information, publicly available information from the Company’s
books and records and all regulatory filings of the Company and to ask questions of
representatives of the Company concerning the terms and conditions of the transactions
contemplated by this Agreement.

 

 

	 	(b)	 	The Purchaser is acquiring the Offered Securities for the Purchaser’s own
account, for investment purposes only, and not with a view to the public sale or
distribution thereof in violation of the Securities Act. The Purchaser understands
that the Offered Securities and the Underlying Common Stock have not been registered
under the Securities Act or registered or qualified under any state securities law in
reliance upon specific exemptions therefrom, which exemptions depend upon, among other
things, the bona fide nature of the Purchaser’s investment intent as expressed herein.
Without limiting the foregoing, the Purchaser makes no representations regarding the
period of time that Purchaser will remain a Holder of the Offered Securities.
	 
	 	(c)	 	The Purchaser is not purchasing the Offered Securities as a result of or
subsequent to any advertisement, article, notice or other communication published in
any newspaper magazine or similar media or broadcast over television or radio or
presented at any seminar.
	 
	 	(d)	 	The Purchaser is, and on the Closing Date will be, able to bear the economic
risk of an investment in the Offered Securities and is able to afford a complete loss
of such investment. The Purchaser has adequate means of providing for the Purchaser’s
current financial needs and contingencies, is able to bear the substantial economic
risks of an investment in the Offered Securities for an indefinite period of time, and
has no need for liquidity in such investment.
	 
	 	(e)	 	The Purchaser acknowledges that the Purchaser has been afforded (i) the
opportunity to ask such questions as he has deemed necessary of, and to receive answers
from, representatives of the Company concerning the terms and conditions of the
offering of the Offered Securities, and the merits and risks of investing in the
Offered Securities; (ii) access to information about the Company and the Company’s
financial condition, results of operations, business, properties, management and
prospects sufficient to enable the Purchaser to evaluate the Purchaser’s investment;
and (iii) the opportunity to obtain such additional information which the Company
possesses or can acquire without unreasonable effort or expense that is necessary to
make an informed investment decision with respect to his investment.
	 
	 	(f)	 	The Purchaser understands and acknowledges that (i) the Offered Securities and,
upon conversion or exercise, the Underlying Common Stock are being offered and sold
without registration under the Securities Act in a private placement that is exempt
from the registration provisions of the Securities Act under Section 4(2) of the
Securities Act and Regulation D promulgated thereunder; (ii) neither of the Offered
Securities nor the Underlying Common Stock have been registered under any Blue Sky law
of any state and (iii) the availability of such exemptions depends in part on, and the
Company is relying on the accuracy, completeness and truthfulness of, the
representations made by Purchaser herein and the statements made by the Purchaser in
the Investor Questionnaire. Purchaser hereby acknowledges and consents to such
reliance by the Company. The Purchaser understands further that in absence of an
effective Registration

 

 

	 	 	 	Statement, the Offered Securities can only be sold pursuant to some exemption from
registration, such as Rule 144 of the Act, which requires, among other conditions,
that the Offered Securities must be held for a minimum of one (1) year.
	 
	 	(g)	 	The Purchaser understands and recognizes that investment in the Offered
Securities involves substantial risks. The Purchaser has, by reason of the Purchaser’s
business or financial experience either alone or together with the Purchaser’s
representatives and professional advisers (who are unaffiliated with and who are not
compensated, directly or indirectly, by the Company or the Placement Agent or any
affiliate of either of them), such knowledge, sophistication and experience in business
and financial matters so as to be capable of evaluating the merits and risks of the
prospective investment in the Offered Securities and the Underlying Common Stock, has
so evaluated the merits and risks of the prospective investment in the Offered
Securities and the Underlying Common Stock. The Purchaser has evaluated the merits and
risks of such investment to such Purchaser’s satisfaction, and has the capacity to
protect Purchaser’s own interests in connection with the Offering. The Purchaser
further acknowledges that he has read the Exchange Act Reports of the Company,
including the risk factors identified therein. The Purchaser further recognizes that
no Federal or state agencies have passed upon the offering of the Offered Securities or
made any finding or determination as to the fairness of this investment.
	 
	 	(h)	 	The Purchaser has made a decision to purchase the Offered Securities based
solely upon the representations and warranties made by the Company in this Agreement,
the Purchaser’s review of the Exchange Act Reports and such other information made
available to the Purchaser by the Company in writing and is not relying on any
investigation or statements made by the Placement Agent. The Purchaser acknowledges
that the Placement Agent cannot make any assurances that the Exchange Act Reports or
other information supplied by the Company are accurate or complete.
	 
	 	(i)	 	The Company confirms that this Section (4)(i) supersedes any legend
requirements of Section 7.03(d) of the Company’s By-Laws, which would otherwise be
applicable to the Offered Securities and the Underlying Common Stock. (i) The
Purchaser acknowledges that each certificate representing the Offered Securities and
the Underlying Common Stock shall contain a legend substantially in the following form:

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 (THE “SECURITIES ACT”) OR
UNDER APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE
SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS
REGISTERED UNDER THE SECURITIES ACT AND ANY
APPLICABLE STATE SECURITIES

 

 

LAWS OR PURSUANT TO AVAILABLE EXEMPTIONS FROM SUCH
REGISTRATION, PROVIDED THAT THE SELLER DELIVERS TO
THE COMPANY AN OPINION OF COUNSEL (WHICH OPINION IS
REASONABLY SATISFACTORY TO THE COMPANY) CONFIRMING
THE AVAILABILITY OF SUCH EXEMPTION. INVESTORS SHOULD
BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE
FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE
PERIOD OF TIME.

	 	 	 	Certificates evidencing the Offered Securities and Underlying Common Stock shall not
contain any legend (including the legend set forth above), (A) while a registration
statement covering the resale of such security is effective under the Securities Act
(provided, however, that the Purchaser’s prospectus delivery requirements under the
Securities Act will remain applicable), or (B) following any sale of such Offered
Securities and/or Underlying Common Stock pursuant to Rule 144, or (C) if such
Offered Securities and/or Underlying Common Stock are eligible for sale under Rule
144(k), or (D) if such legend is not required under applicable requirements of the
Securities Act (including judicial interpretations and pronouncements issued by the
Staff of the SEC). The Company shall use it’s best efforts to cause its counsel to
issue a legal opinion (at the Company’s expense) to the Company’s transfer agent
promptly after the effective date of any registration statement (the “Effective
Date”) if required by the Company’s transfer agent to effect the removal of the
legend hereunder. The Company agrees that following the Effective Date or at such
time as such legend is no longer required under this clause (ii), it will, no later
than five trading days following the delivery by the Purchaser to the Company or the
Company’s transfer agent of a certificate representing Offered Securities and/or
Underlying Common Stock issued with a restrictive legend, deliver or cause to be
delivered to such Purchaser a certificate representing such Offered Securities
and/or Underlying Common Stock that is free from all restrictive and other legends.
The Company may not make any notation on its records or give instructions to any
transfer agent of the Company that enlarge(s) the restrictions on transfer set forth
herein. All costs and expenses related to the removal of the legends and the
reissuance of any Offered Securities or Underlying Common Stock shall be borne by
the Company.
	 
	 	(j)	 	The Company acknowledges and agrees that the Purchaser may from time to time
pledge pursuant to a bona fide margin agreement with a registered broker-dealer or
grant a security interest in some or all of the Offered Securities and/or Underlying
Common Stock to a financial institution that is an “accredited investor” as defined in
Rule 501(a) under the Securities Act and, if required under the terms of such
arrangement, the Purchaser may transfer pledged or secured Offered Securities and/or
Underlying Common Stock to the pledgees or secured parties. Such a pledge or transfer
would not be subject to approval of the Company and no legal opinion of legal counsel
of the pledgee, secured party or

 

 

	 	 	 	pledgor shall be required in connection therewith. Further, no notice shall be
required of such pledge. At the Company’s expense, the Company will execute and
deliver such reasonable documentation as a pledgee or secured party of Offered
Securities and/or Underlying Common Stock may reasonably request in connection with
a pledge or transfer of the Offered Securities and/or Underlying Common Stock,
including, subject to the provisions of Section 2 (g) of the Registration Rights
Agreement, the preparation and filing of any required prospectus supplement under
Rule 424(b)(3) of the Securities Act or other applicable provision of the Securities
Act to appropriately amend the list of selling stockholders thereunder.
	 
	 	(k)	 	The Purchaser has all requisite power and authority to enter into this
Agreement and the Registration Rights Agreement and to consummate the transactions
contemplated hereby and thereby. This Agreement and the Registration Rights Agreement
have been duly executed and delivered by the Purchaser. This Agreement and the
Registration Rights Agreement are legal, valid and binding obligations of the
Purchaser, enforceable against the Purchaser in accordance with their terms, except as
enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium,
fraudulent transfer or conveyance or similar laws relating to or limiting creditors’
rights generally or by equitable principles relating to enforceability and except as
rights of indemnity or contribution may be limited by federal or state securities or
other laws or the public policy underlying such laws.
	 
	 	(l)	 	If Purchaser is a partnership, corporation, trust or estate: (i) such
partnership, corporation, trust or estate has the full legal right and power and all
authority and approval required (a) to execute and deliver, or authorize execution and
delivery of, this Agreement and all other instruments executed and delivered by or on
behalf of such partnership, corporation, trust or estate in connection with the
purchase of the Offered Securities, (b) to delegate authority pursuant to a power of
attorney and (c) to purchase and hold such Offered Securities; (ii) the signature of
the party signing on behalf of such partnership, corporation, trust or estate is
binding upon such partnership, corporation, trust or estate; and (iii) such
partnership, corporation or trust has not been formed for the specific purpose of
acquiring the Offered Securities, unless each beneficial owner of such entity is
qualified as an “accredited investor” within the meaning of Regulation D and has
submitted information substantiating such individual qualification.
	 
	 	(m)	 	If the Purchaser is a retirement plan or is investing on behalf of a retirement
plan, the Purchaser acknowledges that investment in the Offered Securities poses risks
in addition to those associated with other investments, including the inability to use
losses generated by an investment in the Offered Securities to offset taxable income.
	 
	 	(n)	 	No consent, approval, authorization, or order of, or filing with, any
governmental agency or body or any court is required for the consummation of the
transactions

 

 

	 	 	 	contemplated by this Agreement and the Registration Rights Agreement by the
Purchaser, except for such as have been obtained prior to the date hereof.
	 
	 	(o)	 	The information furnished by the Purchaser herein and in the Investor
Questionnaire signed by Purchaser is true and accurate as of the date hereof and will
be true and accurate on the Closing Date, absent notification by the Purchaser to the
Company of any material change in the information contained therein prior to the
Closing Date.
	 
	 	(p)	 	The execution, delivery and performance this Agreement and the Registration
Rights Agreement will not result in a breach or violation of any of the terms and
provisions of, or constitute a default under, any statute, any rule, regulation or
order of any governmental agency or body or any court, domestic or foreign, having
jurisdiction over the Purchaser or any of the Purchaser’s properties, or any agreement
or instrument to which the Purchaser is a party or by which the Purchaser is bound or
to which any of the properties of the Purchaser is subject, or any charter or by-laws
of the Purchaser.
	 
	 	(q)	 	The Purchaser acknowledges that the Placement Agent will receive compensation
from the Company in connection with the offering of the Offered Securities, but is not
guaranteeing or assuming responsibility for the operation or possible liability of the
Company, including, without limitation, compliance by the Company with the agreements
entered into in connection with the offering, and the Placement Agent will not
supervise or participate in the operation or management of the Company.
	 
	 	(r)	 	No person or entity acting on behalf, or under the authority, of the Purchaser
is or will be entitled to any broker’s finder’s or similar fee or commission in
connection with this Agreement or the purchase by the Purchaser of the Offered
Securities.
	 
	 	(s)	 	PURCHASER HEREBY ACKNOWLEDGES THAT THE COMPANY HAS DELIVERED TO THE PURCHASER ALL
INFORMATION AND DOCUMENTS THAT PURCHASER HAS REQUESTED OF THE COMPANY. IN MAKING AN
INVESTMENT DECISION, THE PURCHASER HAS RELIED UPON THE PURCHASER’S OWN EXAMINATION OF
THE COMPANY AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED.
	 
	 	(t)	 	The Purchaser acknowledges that the Placement Agent has been retained by the
Company to act as the Company’s placement agent in the offering of the Offered
Securities and that, for its services, the Placement Agent will be compensated by the
Company as follows: (i) a fee equal to (a) seven percent (7%) of the gross proceeds
from the sale of the Offered Securities, (ii) warrants to purchase three percent (3%)
of the number of shares of the Company’s Common Stock receivable upon conversion of the
Series B Convertible Preferred Stock sold in the Offering, exercisable for a five (5)
year period for one dollar and fifteen cents

 

 

	 	 	 	($1.15) per share, subject to adjustment, and (iii) the reimbursement of certain
expenses.
	 
	 	(u)	 	The Purchaser acknowledges that upon notice of acceptance from the Company,
this Purchase Agreement is irrevocable by the Purchaser, that, except as required by
law, the Purchaser is not entitled to cancel, terminate or revoke this Agreement or any
agreements of Purchaser hereunder and that this Purchase Agreement and such other
agreements shall survive the death or disability of the Purchaser and shall be binding
upon and inure to the benefit of the parties hereto and their respective heirs,
executors, administrators, successors, legal representatives and permitted assigns. If
the Purchaser is more than one person, the obligations of the Purchaser hereunder shall
be joint and several and the agreements, representations, warranties and
acknowledgments herein contained shall be deemed to be made by and be binding upon each
such person and his or her heirs, executors, administrators, successors, legal
representatives and permitted assigns.

	8.	 	Certain Agreements of the Company. The Company agrees with the Purchaser that:

	 	(a)	 	In addition to any and all other public statements or disclosures made by the
Company in its sole discretion (subject to the last sentence of this Section 5(a)), the
Company will issue a press release and file a Current Report on Form 8-K with the
Commission (i) disclosing the material terms of the transaction by the day following
the execution and delivery of the last of the Agreements to be so executed and
delivered by a Purchaser and (ii) regarding the Closing of the purchase and sale of the
Offered Securities, if practicable, on the date of the Closing or the following
morning. Notwithstanding the foregoing, the Company shall not publicly disclose the
name of the Purchaser, or include the name of the Purchaser in any filing with the
Commission or any SRO, without the prior written consent of the Purchaser, except (i)
as required by federal securities law and (ii) to the extent such disclosure is
required by law or regulations, in which case the Company shall provide the Purchaser
with prior notice of such disclosure permitted under sub clause (i) or (ii).
Furthermore, the Company covenants and agrees that neither it nor any other Person
acting on its behalf will provide the Purchaser or its agents or counsel with any
information that the Company believes constitutes material non-public information,
unless prior thereto the Purchaser shall have executed a written agreement regarding
the confidentiality and use of such information. The Company understands and confirms
that the Purchaser shall be relying on the foregoing representations in effecting
transactions in securities of the Company.
	 
	 	(b)	 	The Company shall indemnify and hold the Purchaser harmless from and against
all fees, commissions or other payments owing by the Company to the Placement Agent or
any other person or from acting on behalf of the Company with respect to the Offering.
	 
	 	(c)	 	The Company will pay all expenses incidental to the performance of its
obligations under this Agreement and the Registration Rights Agreement

 

 

	 	 	 	including all expenses in connection with the execution, issue, authentication,
packaging and initial delivery of the Offered Securities and, as applicable, the
Underlying Common Stock, the preparation of this Agreement, the Registration Rights
Agreement, and amendments and supplements thereto, and any other document relating
to the issuance, offer, sale and delivery of the Offered Securities and as
applicable the Underlying Common Stock.
	 
	 	(d)	 	For a period of 90 days after the Effective Date of the Registration Statement,
the Company will not offer, sell, contract to sell, pledge, or otherwise dispose of,
directly or indirectly, any Common Stock or any securities which are convertible into,
or exercisable for, Common Stock, except for (i) shares of Common Stock issued or
issuable pursuant to the Offered Securities, specifically including all shares issuable
upon conversion or exchange of, or as dividends on, the Offered Securities, (ii) shares
of Common Stock issued or issuable pursuant to the Company’s Series A Convertible
Preferred Stock, specifically including all conversion shares and all shares that may
be issued as dividends thereon, (iii) shares of Common Stock issued or issuable
pursuant to the Company’s Series A-1 Warrants, Series A-2 Warrants and Series A-Agent
Warrants, (iv) shares of Common Stock issuable upon the exercise of any options or
warrants outstanding on the date of this Agreement, (v) shares of Common Stock
issuable pursuant to or upon the conversion of any note, debenture, debt instrument and
any other written agreement to which the Company is a party on the date of this
Agreement (vi) shares of Common Stock (including grants, options and warrants) issuable
pursuant to or in accordance with any plan for which the Company has filed a
registration statement that has been declared effective including, without limitation,
the 1994 Stock Plan, the 2005 Stock Plan and the Consultant Compensation Plan, or any
other stock plan, option plan or written agreements to which the Company is a party on
the date of this Agreement including all modifications and replacements thereof, (vii)
shares of Common Stock issuable pursuant to or in accordance with any grants, options,
warrants, conversions or otherwise for which the Company has filed a registration
statement that has been declared effective and (viii) shares of Common Stock issued or
issuable pursuant to the Company’s Series-B-Agent Warrants. (the securities described
in sections (i) through (viii) inclusive may sometimes be referred to herein as the
“Excluded Securities”). The Company will not at any time offer, sell, contract to
sell, pledge or otherwise dispose of, directly or indirectly, any securities under
circumstances where such offer, sale, pledge, contract or disposition would cause the
exemption afforded by Section 4(2) of the Securities Act to cease to be applicable to
the offer and sale of the Offered Securities and the Underlying Common Stock to the
Purchaser hereunder.
	 
	 	(e)	 	The Company shall use the net proceeds received from the sale of the Offered
Securities solely for working capital, including the development of technology.

	9.	 	Conditions of the Obligations of the Purchaser. The obligations of the Purchaser to
purchase and pay for the Offered Securities on the Closing Date will be subject to the
accuracy of the representations and warranties on the part of the Company herein, to the

 

 

	 	 	accuracy of the statements of officers of the Company made pursuant to the provisions
hereof, to the performance by the Company of its obligations hereunder and to the following
additional conditions precedent:

	 	(a)	 	The Company shall have executed this Agreement and the Registration Rights
Agreement and delivered the same to the Placement Agent.
	 
	 	(b)	 	The Purchaser shall have received copies of all documents and information,
which it may have reasonably requested in connection with the offering and sale of the
Offered Securities.
	 
	 	(c)	 	The Company shall have caused its corporate and securities legal counsel,
respectively, to deliver to the Purchaser the legal opinions in substantially the forms
together attached hereto as Exhibit A.
	 
	 	(d)	 	The Company shall have caused its intellectual property counsel to deliver to
the Purchaser a legal opinion relating to the Intellectual Property substantially in
the form attached hereto as Exhibit B.
	 
	 	(e)	 	No stop order or suspension of trading shall have been imposed by Nasdaq, the
Commission, any SRO or any other governmental regulatory body with respect to public
trading in Common Stock of the Company.
	 
	 	(f)	 	Subsequent to the execution and delivery of this Agreement, but prior to the
respective Closing Date for such Purchaser there shall not have occurred (i) a change
in U.S. or international financial, political or economic conditions or currency
exchange rates or exchange controls as would, in the judgment of the Placement Agent,
be likely to prejudice materially the success of the proposed issue, sale or
distribution of the Offered Securities, whether in the primary market or in respect of
dealings in the secondary market, or (ii) (A) any change, or any development or event
involving a prospective change, in the condition (financial or other), business,
properties or results of operations of the Company and its Subsidiaries taken as one
enterprise which, in the judgment of the Purchaser is material and adverse and makes it
impractical or inadvisable to proceed with completion of the offering or the sale of
and payment for the Offered Securities; (B) any material suspension or material
limitation of trading in securities generally on NASDAQ or any setting of minimum
prices for trading on NASDAQ, or any suspension of trading of any securities of the
Company on any exchange or in the over-the-counter market; (D) any banking moratorium
declared by United States Federal or New York authorities; or (E) any outbreak or
escalation of major hostilities in which the United States is involved, any declaration
of war by Congress or any other substantial national or international calamity or
emergency if, in the judgment of the Purchaser, the effect of any such outbreak,
escalation, declaration, calamity or emergency makes it impractical or inadvisable to
proceed with completion of the offering or sale of and payment for the Offered
Securities.

 

 

	 	(g)	 	The Purchaser shall have received a certificate, dated such Closing Date, of
the Chief Executive Officer or President the principal financial or accounting officer
of the Company in form a substance reasonably satisfactory to the Placement Agent and
its counsel, in which such officers, to the effect that the representations and
warranties of the Company in this Agreement are true and correct, that the Company has
complied with all agreements and satisfied all conditions on its part to be performed
or satisfied hereunder at or prior to such Closing Date, and that there has been no
development or event that would constitute a Material Adverse Effect, nor any
development or event known to the Company that prospectively involves a Material
Adverse Effect.
	 
	 	(h)	 	The Offering shall have resulted in gross proceeds of $7,000,000 or more being
made available to the Company, provided that, the Company and the Placement Agent may
agree, without notice to any Purchaser, to reduce the required amount of minimum gross
proceeds being made available to the Company as a result of the Offering to any amount
not less than $5,000,000 at any time following the execution hereof, in their sole and
absolute discretion.
	 
	 	(i)	 	The Company and the Company’s transfer agent shall have executed irrevocable
instructions in the form attached hereto as Exhibit C (the “Irrevocable Transfer Agent
Instructions”), instructing such transfer agent, and any subsequent transfer agent, to
promptly issue certificates, registered in the name of each Purchaser or its respective
nominee(s), for the Underlying Common Stock in such amounts as specified from time to
time by the Purchaser to the Company upon conversion of the Series B Convertible
Preferred Stock and/or upon exercise of the Series B Warrants.
	 
	 	(j)	 	The Purchaser shall have received a certificate evidencing the incorporation
and good standing of the Company in Nevada issued by the Secretary of State of the
State of Nevada as of a date within ten (10) days of the Closing Date, together with a
certificate evidencing the good standing of the Company as a foreign corporation in the
State of Texas issued by the Secretary of State of the State of Texas.
	 
	 	(k)	 	The Purchaser shall have received a certified copy of the Certificate of
Incorporation and the Certificate of Designations, as certified by the Secretary of
State of the State of Nevada as of a date within ten (10) days of the Closing Date.
	 
	 	(l)	 	The Purchaser shall have received from the Company a secretary’s certificate,
dated as of the Closing Date, certifying as to (A) resolutions, (B) the Articles of
Incorporation and (C) the Bylaws, each as in effect at the date hereof.
	 
	 	(m)	 	The Company will furnish the Purchaser such number of conformed copies of such
opinions, certificates, letters and documents as the Purchaser may reasonably request
in writing. Any Purchaser may in its sole discretion waive compliance with any
conditions to the obligations of the Purchaser hereunder.

 

 

	10.	 	Survival of Certain Representations and Obligations. The respective indemnities,
agreements, representations, warranties and other statements of the Company or its officers
and of the Purchaser set forth in or made pursuant to this Agreement will remain in full force
and effect, regardless of any investigation, or statement as to the results thereof, made by
or on behalf of the Purchaser, the Company or any of their respective representatives,
officers or directors or any controlling person, and will survive delivery of and payment for
the Offered Securities.
	 
	11.	 	Notices. All notices, requests, demands, waivers, consents and other communications
hereunder shall be in writing, and (i) if sent to the Purchaser or the Placement Agent shall
be delivered either in person, by telegraphic, facsimile, or other electronic means, by
overnight air courier or by as certified or registered mail, return receipt requested or (ii)
if sent to the Company, shall be delivered either in person, by telegraphic, facsimile, or
other electronic means, by overnight air courier, and shall be deemed to have been duly given
and to have become effective: (a) upon receipt if delivered in person or by telegraphic,
facsimile or other electronic means calculated to arrive on any Business Day prior to 5:00
p.m., local time, or on the next succeeding Business Day if delivered on a non-business day or
after 5:00 p.m., local time; (b) one Business Day after having been delivered to an air
courier for overnight delivery or (c) three Business Days after having been deposited in the
United States mails as certified or registered mail, return receipt requested, all fees
prepaid, directed to the parties at the following addresses (or at such other address as shall
have been previously given in writing in accordance with the terms hereof by any party
hereto):

If to Purchaser,

to the address set forth on

the signature page hereof.

If to Viseon, Inc.:

Viseon, Inc.

Attn: President

8445 Freeport Parkway Suite 245

Dallas, TX 75063

With a copy to:

Albert B. Greco, Jr.

Law Offices of Albert B. Greco, Jr.

16901 N. Dallas Parkway, Suite 230

Addison, Texas 75001

Facsimile: 972-818-7343

	12.	 	Counterparts. This Agreement may be executed in any number of counterparts, each of
which shall be deemed to be an original, but all such counterparts shall together constitute
one and the same Agreement.

 

 

	13.	 	Applicable Law: Consent to Jurisdiction. This Agreement shall be governed by, and
construed in accordance with, the laws of the State of New York without regard to principles
of conflicts of laws. The Purchaser hereby submits to the exclusive jurisdiction of the
Federal and State courts situated in New York County, New York in any suit or proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby.
	 
	14.	 	Changes. This Agreement may not be modified, amended or waived except pursuant to an
instrument in writing signed by the Company and the Purchaser.
	 
	15.	 	Entire Agreement. This Agreement constitutes the entire agreement between the
parties hereto pertaining to the subject matter hereof, and any and all other written or oral
agreements relating to such subject matter are expressly cancelled.
	 
	16.	 	Successors and Assigns. This Agreement shall inure to the benefit of and be binding
upon the successors and permitted assigns of the Company and the Purchaser, including without
limitation and without the need for an express assignment, affiliates of the Purchaser. The
Company may not assign this Agreement or any rights or obligations hereunder without the prior
written consent of the Purchaser. Upon any transfer, the Company shall be obligated to such
transferee to perform all of its covenants under this Agreement as if such transferee were an
Purchaser.
	 
	17.	 	Remedies. In addition to being entitled to exercise all rights provided herein or
granted by law, including recovery of damages, the Purchaser and the Company will be entitled
to specific performance under the Agreement. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations
described in the foregoing sentence and hereby agree to waive in any action for specific
performance of any such obligation the defense that a remedy at law would be adequate.
	 
	18.	 	Independent Nature of Purchaser’s Obligations and Rights. The obligations of the
Purchaser under this Agreement are several and not joint with the obligations of any other
purchaser under any other agreement, and the Purchaser shall not be responsible in any way for
the performance of the obligations of any other purchaser under any other agreements. The
decision of the Purchaser to purchase Offered Securities pursuant to this Agreement has been
made by such Purchaser independently of any other purchaser. Nothing contained herein or in
any of the other agreement, and no action taken by Purchaser pursuant thereto, shall be deemed
to constitute the Purchaser and any other purchasers as a partnership, an association, a joint
venture or any other kind of entity, or create a presumption that the Purchaser is in any way
acting in concert or as a group with others with respect to such obligations or the
transactions contemplated hereby. The Purchaser acknowledges that no other purchaser has
acted as agent for Purchaser in connection with making its investment hereunder and that no
other purchaser will be acting as agent of the Purchaser in connection with monitoring its
investment in the Offered Securities and Underlying Common Stock or enforcing its rights under
this Agreement. The Purchaser shall be entitled to independently protect and enforce its
rights, including without limitation the rights arising out of this Agreement, and it shall

 

 

	 	 	not be necessary for any other purchaser to be joined as an additional party in any
proceeding for such purpose.
	 
	19.	 	Replacement of Offered Securities and/or Underlying Common Stock. If any certificate
or instrument evidencing any Offered Securities and/or Underlying Common Stock is mutilated,
lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and
substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new
certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the
Company of such loss, theft or destruction and customary and reasonable indemnity, if
requested. The applicants for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs associated with the issuance of such replacement
Offered Securities and/or Underlying Common Stock.
	 
	20.	 	Stock Splits, Etc. The provisions of this Agreement shall be appropriately adjusted
to reflect any stock split, stock divided, reverse stock split, reorganization or other
similar event effected after the date hereof.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their
duly authorized representatives as of the day and year first above written.

[Signature page follows]

 

 

ACCEPTED AND AGREED:

	 	 	 	 	 	 	 
	Number of Offered Securities Being Purchased:	 	 
	 
	 	 	 	 	 	 
	 	 	Series B Convertible Preferred Stock:                                        
	 
	 	 	 	 	 	 
	 	 	Series B Warrants:                                        
	 
	 	 	 	 	 	 
	The Offered Securities	 	 	 	 
	 	 	 	 	 	 	 
	Are to be issued in (check one box):	 	Print Name of Purchaser	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	o individual name	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Print Name of Joint Purchaser
(if applicable)	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	o joint tenants
with rights of Survivorship	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Signature of Purchaser	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	o tenants in the Entirety	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Signature of Joint Purchaser	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	o corporation (an officer must sign)	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Address of Purchaser	 	 
	 
	 	 	 	 	 	 
	o partnership (all general Partners
must sign)	 	 	 	 
	 
	 	 	 	 	 	 
	o limited liability company	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Accepted as of August ___, 2005	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Viseon, inc.	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	By: John Harris, President	 	 	 	 

 

 

SUMMARY INSTRUCTION SHEET FOR PURCHASER

(to be read in conjunction with the entire

Purchase Agreement which this follows)

A. Complete the following items on BOTH Purchase Agreements (Please sign two originals):

	 	1.	 	Page 29 — Signature:

	 	(i)	 	Name of Purchaser (Individual or Institution)
	 
	 	(ii)	 	Name of Individual representing Purchaser (if an Institution)
	 
	 	(iii)	 	Title of Individual representing Purchaser (if an Institution)
	 
	 	(iv)	 	Signature of Individual Purchaser or Individual representing Purchaser

	 	2.	 	Appendix I — Investor Questionnaire:
	 
	 	 	 	Provide the information requested by the Investor Questionnaire.
	 
	 	3.	 	Return BOTH properly completed and signed Purchase Agreements including the
properly completed Appendix I to (initially by facsimile with hand copy by overnight
delivery):

ThinkEquity Partners LLC

31 West 52nd Street, 17th Floor

New York, New York 10019

Attention: Nicholas Oust

Facsimile: (212) 468-7044

     B. Instructions regarding the transfer of funds for the purchase of the Securities will be sent by
facsimile to the Purchaser by the Placement Agent at a later date.

     C. Upon the resale of the Shares or the Warrant Shares by the Purchasers after the Registration
Statement covering the Shares and the Warrant Shares is effective, as described in the Purchase
Agreement, the Purchaser:

	 	(i)	 	must deliver a current prospectus of the Company to the buyer
(prospectuses must be obtained from the Company at the Purchaser’s request);
and
	 
	 	(ii)	 	must send a notice of sale in the form of Appendix II to the
Company so that the Shares or Warrant Shares may be properly transferred.

 

 

APPENDIX I

INVESTOR QUESTIONNAIRE

 

     This questionnaire is being delivered to you by Viseon, Inc. (the “Company”) in connection
with the preparation of a Registration Statement on Form SB-2, (the “Registration Statement”)
pursuant to the Securities Act of 1933. The purpose of this questionnaire is to develop and verify
information used in preparation of the Registration Statement.

     If documents filed with the SEC contain any untrue statements or omit to state any material
fact, you, the Company and its respective officers, directors and controlling persons may be
subject to civil or criminal liabilities under the Securities Act of 1933. It is important,
therefore, that the information you supply be complete and accurate.

     Since the definitions of certain terms used in the questionnaire may be unfamiliar to you, you
may find it helpful to read the entire questionnaire and the definitions found throughout before
answering any of the questions. Particularly, the concepts of “voting power” and “investment
power” are important. “Voting power” means the power to vote, or to direct the voting of, the
shares, while “investment power” includes the power to dispose, or to direct the disposition, of
the shares. Other important concepts relating to “voting power” and “investment power” deal with
whether or not one or both of such powers are “sole” or “shared.” You have sole “voting power” or
sole “investment power” if you do not share these powers with any other person. You have shared
“voting power” or shared “investment power” if you share these powers with any other person.

     A response should be made to each item in the questionnaire. Indicate a negative response or
“not applicable” where appropriate. If inadequate space is provided for your answer, write on the
back of the page or attach a rider.

     AN INCORRECT OR INCOMPLETE ANSWER TO ANY OF THE QUESTIONS COULD SUBJECT THE COMPANY AND YOU
PERSONALLY TO LIABILITY UNDER THE SECURITIES LAWS. ACCORDINGLY, PLEASE GIVE THE QUESTIONNAIRE YOUR
CAREFUL ATTENTION.

 

 

APPENDIX
I

Part I. Identification of Holder

	 	 	 
	The exact name that your Securities are to be registered in (this is
the name that will appear on your stock certificate(s)). You may use
a nominee name if appropriate:
	 	 
	 	 	 
	 
	 	 
	The relationship between the Purchaser of the Securities and the
Registered Holder listed in response to item 1 above:
	 	 
	 	 	 
	 
	 	 
	The mailing address of the Registered Holder listed in response to
item 1 above:
	 	 
	 	 	 
	 
	 	 
	The Social Security Number or Tax Identification Number of the
Registered Holder listed in response to item 1 above:
	 	 
	 	 	 

 

 

APPENDIX
I

Part II. Holding of Securities

1
Securities Owned Outright by You. State below the number of shares of Common Stock that you
owned outright as of the date hereof. Include shares registered in your name individually and
shares held in the name of a bank, broker, nominee, depository or in “Street Name” for your
account. If the answer is none, please so state. You are presumed to have sole “voting power” and
sole “investment power” of all shares you own outright. If for any reason you do not have sole
“voting power” or sole “investment power” of all shares you own outright, please describe the
reasons for your lack of sole powers.

	 	 	 	 	 	 	 
	 

	 	Common Stock	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Description of any reasons for lack of shared “voting power” or shared “investment
power”:
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 

2 Securities Owned Jointly by You. State below the number of shares of Common Stock that you owned
directly but jointly with others as of the date hereof, even if the shares are held in the name of
a bank, broker, nominee, depository or in “Street Name” for your account. If the answer is none,
please so state. You are presumed to have shared “voting power” and shared “investment power” of
all shares you own jointly. If for any reason you do not share with another person “voting power”
or “investment power” of all shares you own jointly, please describe the reasons for your lack of
shared powers.

	 	 	 	 	 	 	 
	 

	 	Common Stock	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	Identities of Joint Owners	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	Description of any reasons for lack of shared “voting power” or shared “investment
power”:
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 

3 Other Shares over Which You Have or Share Voting Power and/or Investment Power.

	 	(a)	 	State below the number of shares of Common Stock over which you indirectly
(through any corporation or other entity) or through any contract, arrangement,
understanding, relationship or otherwise, have sole or shared “voting power” or
“investment power” or both as of the date hereof, even though the shares are not held
for your direct benefit.

	 	 	 	 	 
	 

	 	Common Stock	 	 
	 

	 	 	 	 

	 	(b)	 	For any shares reported pursuant to question 3(a) above, please indicate
whether your “voting power” and/or “investment power” is sole or shared and provide all
relevant details, such as (if applicable) with whom the power is shared, the nature of
the relationship and any underlying voting trust agreement, investment arrangement or
the like.

 

 

APPENDIX
I

	 	(c)	 	For any shares reported pursuant to question 3(a) above, please also set forth
all other relevant information, such as a general indication of your capacity as
fiduciary, if any, and/or the name and nature of any party in whose name(s) any shares
are registered.

4 Disclaimer of Beneficial Ownership. The SEC’s definition of “beneficial ownership” for purposes
of the Registration Statement includes any securities of the Company over which you have “voting
power” or “investment power” as defined above. In certain circumstances, however, it may be
possible to disclaim this type of beneficial ownership. As to any shares listed above, if you wish
expressly to disclaim beneficial ownership for any purpose in the Registration Statement, please
indicate below the shares with respect to which you wish to disclaim beneficial ownership and the
basis for the disclaimer.

5 Securities Which You Have the Right to Acquire within 60 Days.

	 	(a)	 	State below the number of shares of Common Stock as to which you have the right
to acquire “voting power” and/or “investment power” within 60 days of the date hereof,
including, but not limited to, any right to acquire shares (a) upon the exercise of any
option, warrant or right; (b) upon the conversion of a security; (c) pursuant to the
power to revoke a trust, discretionary account or similar arrangement; or (d) pursuant
to the automatic termination of a trust, discretionary account or similar arrangement.
(Do not include shares listed in questions 1, 2 or 3 above.) Please also briefly
describe the nature of your right to acquire.

	 	 	 	 	 
	 

	 	Common Stock	 	 
	 

	 	 	 	 

	 	(b)	 	For any shares reported pursuant to question 5(a) above, please indicate
whether your “voting power” and/or “investment power” will be sole or shared and
provide all relevant details, such as (if applicable) with whom the power will be
shared and the nature of the relationship that will give you such power.
	 
	 	(c)	 	As to any shares listed in question 5(a) above, if you wish expressly to
disclaim beneficial ownership for any purpose in the Registration Statement, please
indicate below the shares and circumstances.

6 Duplication of Ownership of Your Securities. Please state whether, to your knowledge, any of the
Reporting Persons (as defined at the end of this Question 6) shares ownership of, or “voting power”
or “investment power” over, any shares of Common Stock reported by you. Specifically identify any
such securities, identify which of the Reporting Persons shares ownership, “voting power” or
“investment power” and briefly describe the relationship by which the Reporting Person shares
ownership, “voting power” or “investment power”. For purposes of this Question 6, “Reporting
Persons” include the following persons:

Richard Craven

Brian Day

Digital Investors, LLC

Geoffrey Gerard

Albert B. Greco, Jr.

 

 

APPENDIX
I

John C. Harris

Henry F. Harris, Sr.

Henry C.S. Mellon

John O’Donnell

Pequot Capital Management, Inc.

Charles Rey

Schottenfeld Qualified Associates, LP

Richard Schottenfeld

Robert Wolf

7 Securities Owned by Your Family and Certain Relatives. Please set forth below the number of
shares of Common Stock registered in the name of, or otherwise owned by, your spouse, minor
children or your spouse’s or your relatives who live in your home. Indicate separately the
identity of the owner of all such shares. In the past, the SEC has taken the position that such
shares will ordinarily be regarded as “beneficially owned” by you, although absent special or
unusual circumstances you are not the “beneficial owner” of such shares under the SEC’s definition
of “beneficial ownership” for purposes of the Registration Statement, since you do not have “voting
power” or “investment power” (as defined above) over them. Unless special or unusual circumstances
obtain, therefore, these shares will not be included in the holdings of securities of the Company
shown for you in the Registration Statement. Depending on the number of such shares and certain
other factors, however, it may be necessary to refer to such shares in a footnote in the
Registration Statement for disclosure or clarification purposes. If such a reference is made, we
will include an appropriate disclaimer of ownership.

	 	 	 	 	 
	 

	 	Common Stock	 	 
	 

	 	 	 	 

8 Certain Securities Held in Trust for Your Benefit. Please set forth below the number of shares
of Common Stock (i) held in a trust in which you have the right to the income (in whole or in part)
only and/or (ii) held in a trust in which you have a right to the principal (in whole or in part)
on or after the date hereof. Indicate shares and factual circumstances. [As noted above, although
absent special or unusual circumstances you are not the “beneficial owner” of such shares under the
SEC’s definition of “beneficial ownership” for purposes of the Registration Statement, it may be
necessary to refer to the shares held in trust in the Registration Statement for disclosure or
clarification purposes. If such a reference is made, we will include an appropriate disclaimer of
ownership.]

	 	 	 	 	 
	 

	 	Common Stock	 	 
	 

	 	 	 	 

 

 

APPENDIX I

Part III. Miscellaneous

1 Broker-Dealer Status.

	 	(a)	 	Please mark the appropriate statement below (one of the two statements must be
marked).
	 
	 	o	 	I am a broker-dealer or an affiliate of a broker-dealer.
	 
	 	o	 	I am neither a broker-dealer nor an affiliate of a broker-dealer.
	 
	 	(b)	 	If you indicated that you are a broker-dealer or an affiliate of a
broker-dealer, Please mark the appropriate statement below (one of the two statements
must be marked).
	 
	 	o	 	I acquired the securities being registered on my behalf in the ordinary course
of business

	 	o	 	I acquired the securities being registered on my behalf other than in the
ordinary course of business

	 	(c)	 	If you indicated that you are a broker-dealer or an affiliate of a
broker-dealer, please mark the appropriate statement below (one of the two statements
must be marked).
	 
	 	o	 	At the time I acquired the securities being registered on my behalf, I had
entered into an agreement, understanding or arrangement with another person, either
directly or indirectly, to dispose of these securities
	 
	 	o	 	At the time I acquired the securities being registered on my behalf, I had not
entered into an agreement, understanding or arrangement with another person, either
directly or indirectly, to dispose of these securities
	 
	 	(d)	 	If you indicated that you are a broker-dealer or an affiliate of a
broker-dealer, please provide immediately below a summary of the relevant details
relating to this status.

2 Open Short Positions.

	 	(a)	 	Please mark the appropriate statement below (one of the two statements must be
marked).

	 	o	 	I currently have an open short position in the Common Stock.
	 
	 	o	 	I do not currently have an open short position in the Common Stock.

	 	(b)	 	Please read the excerpt set forth below, which contains a telephone
interpretation rendered by the staff of the SEC. After reading the excerpt, please
acknowledge that you have done so by marking the blank set forth immediately after the excerpt.

 

 

APPENDIX I

“An issuer filed a Form S-3 registration statement for a secondary offering of
common stock which is not yet effective. One of the selling shareholders wanted to
do a short sale of common stock “against the box” and cover the short sale with
registered shares after the effective date. The issuer was advised that the short
sale could not be made before the registration statement becomes effective, because
the shares underlying the short sale are deemed to be sold at the time such sale is
made. There would, therefore, be a violation of Section 5 if the shares were
effectively sold prior to the effective date.”

	 	o	 	I have read the excerpt set forth above.

3 Control Persons. A response to this question is required only of selling shareholders that are
entities. If the selling shareholder completing this questionnaire is an entity, such selling
shareholder should identify below the one or more individuals (i.e. natural persons) who exercise
the voting and dispositive powers with respect to the shares of Common Stock being registered on
behalf of such selling shareholder.

     This will confirm that the information given in answer to the items set forth above is true,
correct and complete. If no information is furnished with respect to any questions, you are hereby
authorized to assume that the answer is “Negative”, “No”, “None” or “Not Applicable”, as the case
may be.

 

printed name of holder:

	 	 	 	 	 	 	 
	By:
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Date:	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Name:
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Title:
	 	 	 	 	 	 
	 

	 	 	 	 	 	 

 

 

APPENDIX II

Print or Type:

	 	 	 	 	 
	 	 	 
	[Transfer Agent]	 	 
	 
	 	 	 	 
	 	 	 
	[Address]	 	 
	 
	 	 	 	 
	Attention:
	 	 	 	 
	 

	 	 	 	 

PURCHASER’S CERTIFICATE OF SUBSEQUENT SALE

	 	 	 
	The undersigned, [individually/ as an officer of/ a person duly authorized by]
	 	 
	 

	 	hereby certifies
	 
	 	 
	[fill in exact name of individual or institution as listed on share certificate]
	 	 
	that [he/she/said institution] is the Purchaser of the shares evidenced by the attached certificate,
and as such, sold such shares on 

                     in accordance with the terms of the Purchase
	[date]
	 	 
	Agreement and in accordance with Registration Statement number
	 	 
	 

	 	 
	 

	 	[fill in the number of or otherwise
	 

	 	identify the Registration Statement]
	or otherwise in accordance with the Securities Act of 1933, as amended, and, in the case of a
transfer
pursuant to the Registration Statement, the requirement of delivering a current prospectus by the
Company has been complied with in connection with such sale.

	 	 	 
	Name of Purchaser
	 	 
	(Individual or Institution)
	 	 
	 

	 	 
	 
	 	 
	Name of Individual
	 	 
	representing Purchaser
	 	 
	(if an Institution)
	 	 
	 

	 	 
	 
	 	 
	Title of Individual
	 	 
	representing Purchaser
	 	 
	(if an Institution):
	 	 
	 

	 	 
	 
	 	 
	Signature by: Individual Purchaser
	 	 
	or Individual representing Purchaser:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]